ResearcherNanjing Drum Tower HospitalActive in the last 2 years

Liang Qi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5114215192. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 3

Construction of feature selection and efficacy prediction model for transformation therapy of locally advanced pancreatic cancer based on CT, 18F-FDG PET/CT, D… Co-author DOI 10.1186/s12935-025-03639-8 ↗
Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical t… Co-author DOI 10.1007/s00262-024-03744-z ↗
Making "cold" tumors "hot"- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit from immunotherapy: a case report. Co-author DOI 10.3389/fimmu.2023.1277810 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Juan Du · 2 shared papers, 2023–2025 · strength 0.43
- Paper Construction of feature selection and efficacy prediction model for transformation therapy of locally advanced pancreat… DOI 10.1186/s12935-025-03639-8 ↗
- Paper Making "cold" tumors "hot"- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit fro… DOI 10.3389/fimmu.2023.1277810 ↗
Baorui Liu · 2 shared papers, 2023–2025 · strength 0.43
- Paper Construction of feature selection and efficacy prediction model for transformation therapy of locally advanced pancreat… DOI 10.1186/s12935-025-03639-8 ↗
- Paper Making "cold" tumors "hot"- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit fro… DOI 10.3389/fimmu.2023.1277810 ↗
Fan Tong · 2 shared papers, 2023–2024 · strength 0.37
- Paper Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic c… DOI 10.1007/s00262-024-03744-z ↗
- Paper Making "cold" tumors "hot"- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit fro… DOI 10.3389/fimmu.2023.1277810 ↗
Xiang Li · 1 shared paper, 2025 · strength 0.27
- Paper Construction of feature selection and efficacy prediction model for transformation therapy of locally advanced pancreat… DOI 10.1186/s12935-025-03639-8 ↗
Juan Du · 1 shared paper, 2024 · strength 0.20
- Paper Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic c… DOI 10.1007/s00262-024-03744-z ↗
Qin Wang · 1 shared paper, 2024 · strength 0.20
- Paper Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic c… DOI 10.1007/s00262-024-03744-z ↗
Juan Liu · 1 shared paper, 2024 · strength 0.20
- Paper Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic c… DOI 10.1007/s00262-024-03744-z ↗
Huizi Sha · 1 shared paper, 2023 · strength 0.17
- Paper Making "cold" tumors "hot"- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit fro… DOI 10.3389/fimmu.2023.1277810 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.